Health Media ArticlesExcerpts of Key Health Media Articles in Major Media
Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.
For further exploration, delve into our comprehensive Health and Food Corruption Information Center.
Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
When you buy a gallon of organic milk, you expect to get tasty milk from happy cows who haven't been subjected to antibiotics, hormones or pesticides. But you might also unknowingly be getting genetically modified cattle feed. Albert Straus, owner of the Straus Family Creamery ... decided to test the feed that he gives his 1,600 cows last year and was alarmed to find that nearly 6% of the organic corn feed he received from suppliers was "contaminated" by genetically modified (GM) organisms. Organic food is, by definition, supposed to be free of genetically modified material. But as GM crops become more prevalent, there is little that an organic farmer can do to prevent a speck of GM pollen or a stray GM seed from being blown by the wind onto his land. In 2006, GM crops accounted for 61% of all the corn planted in the U.S. and 89% of all the soybeans. So Straus and five other natural food producers, including industry leader Whole Foods, announced last week that they would seek a new certification for their products, "non-GMO verified," in the hopes that it will become a voluntary industry standard for GM-free goods. In a few weeks, Straus expects to become the first food manufacturer in the country to carry the label in addition to his "organic" one. With Whole Foods in the ring, the rest of the industry will soon be under competitive pressure to follow. Genetically modified crops have become so prevalent in the U.S. that chances are you've been buying and eating them for years. You just wouldn't know it from the label: the U.S. Department of Agriculture, unlike agencies in Europe and Japan, do not require GM foods to be labeled.
Note: This article also states "scientists have not identified any specific health risks from eating GM foods." This is a clear lie, when two sentences later the article mentions Jeffrey Smith, who has written an entire book with excellent documentation showing many scientific studies in which animals died shortly after consuming GM foods. To see an excellent summary of this book including reliable footnotes, click here.
Many myths and misconceptions about the AIDS pandemic are spread by the Joint United Nations Program on HIV/AIDS (UNAIDS) and other mainstream AIDS agencies and activists. UNAIDS continues to perpetuate the fallacy that only aggressive HIV/AIDS prevention programs ... can prevent the eruption of heterosexual HIV epidemics. More than two decades of observation and analysis point to far different conclusions -- there are no "next waves" of HIV epidemics just around the corner. UNAIDS and most AIDS activists reject this analysis. However, all available epidemiologic data show that only the highest risk sexual behavior ... drives HIV epidemics among heterosexuals. Most AIDS activists claim, without any supporting data, that high HIV prevalence in groups of men who have sex with men or injecting drug users will inevitably "bridge" over to the rest of the population and lead to "generalized" HIV epidemics. This entrenched myth persists even though there is little, if any, HIV spread into any "general" population. Global and regional HIV rates have remained stable or have been decreasing during the past decade. HIV has remained concentrated in groups with the riskiest behavior. HIV is incapable of epidemic spread among the vast majority of heterosexuals. Most of the public, policymakers and media have no inkling that the UNAIDS working assumption is inconsistent with established facts. Scarce health resources in countries with low HIV prevalence should be targeted primarily at those who are at the highest HIV risk, instead of being misdirected to the wider public.
Government officials were made aware of some problems with a version of the MMR vaccine in other countries but still introduced it in Britain in the late 1980s, newly released documents show. The MMR vaccine with the Urabe strain of mumps was first used in Britain in October 1988. It was blamed for the deaths of several children after being withdrawn by the Department of Health in September 1992. Previously confidential documents released under the Freedom of Information Act show how officials gradually learned of the dangers of the Urabe strain MMR which caused encephalitis-type conditions, including meningitis. Many months before the Urabe MMR vaccine was introduced in the UK, officials were made aware of problems in America, Sweden and Canada. The first warning came when an unnamed official at a meeting of the Government's Joint Committee of Vaccination and Immunisation in May 1987 "expressed his reservations concerning reported adverse reactions to MMR in the USA". The second came in a letter from ... Sweden in September that year, where authorities reported "52 cases of febrile convulsions probably associated with MMR vaccination". Then, a Government working party ... learned of "a report of cases of mumps encephalitis'' in Canada at a meeting in Feb 1988. The UK went ahead with its nationwide MMR programme in October 1988 in which 85 per cent of the triple-vaccinations contained Urabe.
Note: For more along these lines, see concise summaries of deeply revealing news articles on vaccine risks from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
The Agriculture Department has given a preliminary green light for the first commercial production of a food crop engineered to contain human genes, reigniting fears that biomedically potent substances in high-tech plants could escape and turn up in other foods. The plan ... calls for large-scale cultivation in Kansas of rice that produces human immune system proteins in its seeds. The proteins are to be extracted for use as an anti-diarrhea medicine and might be added to health foods such as yogurt and granola bars. Critics are assailing the effort, saying gene-altered plants inevitably migrate out of their home plots. In this case, they said, that could result in pharmacologically active proteins showing up in the food of unsuspecting consumers. Although the proteins are not inherently dangerous, there would be little control over the doses people might get exposed to, and some might be allergic to the proteins, said Jane Rissler of the Union of Concerned Scientists. "This is not a product that everyone would want to consume," Rissler said, adding that other companies grow such plants indoors or in vats. "It is unwise to produce drugs in plants outdoors."
Note: For a detailed analysis of the dangers of this genetically-modified rice program, click here.
Japanese health authorities are investigating a flu medicine that is also available in Australia after a teenager jumped 11 storeys to his death after taking the drug. It was the 18th juvenile fatality linked to Tamiflu in 17 months. The Ministry of Health, Labour and Welfare has asked the Japanese importer of Tamiflu, an anti-viral drug regarded as the most important shield against bird flu in humans, to collect information about the conditions of patients who take the drug. The 14-year-old boy's death follows a similar case two weeks ago, when a girl also 14, died after jumping from an apartment building at Gamagori, in central Japan. It also comes after a warning by the US Food and Drug Administration late last year about the dangers of giving children Tamiflu. The drug is being stockpiled in Australia as the first line of defence against bird flu. In Australia, as in Japan, it is only available by prescription. Drug companies reported that 54 people using Tamiflu died in Japan before November, the ministry said.
Note: Tamiflu is the vaccine on which Donald Rumsfeld profited $5 million and on which the U.S. government has spent hundreds of millions of dollars stockpiling, even though it might not work. For more, click here.
A Florida man with no medical training has invented a machine that he believes may lead to a cure for cancer. John Kanzius ... wondered if his background in physics and radio could come in handy in treating the disease from which he suffers himself. After 24 rounds of chemotherapy, the former broadcaster decided that he did not want to see others suffer trying to cure the disease. Kanzius said it was watching kids being treated that affected him the most. "Particularly, young children walk in with smiles, and then you'd see them three weeks later and their smiles had disappeared. I said to myself, 'We're in a barbaric type of medicine." Kanzius said his machine basically makes cells act like antennae to pick up a signal and self-destruct. Unlike current cancer treatment, Kanzius' machine does not use radiation, and unlike today's radio-frequency treatments, it's noninvasive. Now, some of the nation's most prominent doctors and scientists are using Kanzius' machines in their research. In January, researchers said they performed a breakthrough at the M. D. Anderson Cancer Center in Houston. "The complete killing of pancreatic cells in laboratory conditions is encouraging," Dr. Steve Curley said. Kanzius explained that his machine uses a solution filled with nanoparticles, which measure no more than one-billionth of a meter. A test subject would be injected with either gold or carbon nanoparticles, which would make their way through the body and attach to the cancerous cells. The test subject would then enter the machine and receive a dose of radio frequency waves, theoretically heating and killing the cancerous cells in moments and leaving nearby cells untouched.
Note: For more on this exciting machine and the man behind it, click here. For other major media articles relating potential cancer cures, click here.
Gov. Rick Perry on Thursday angrily defended his relationship with Merck & Co. and his executive order requiring that schoolgirls receive the drugmaker's vaccine against the sexually transmitted cervical-cancer virus. The Associated Press reported Wednesday that Perry's chief of staff had met with key aides about the vaccine on Oct. 16, the same day Merck's political action committee donated $5,000 to the governor's campaign. In issuing the order, the governor made Texas the first state to require the vaccine Gardasil for all schoolgirls. But many lawmakers have complained about his bypassing the Legislature altogether. The executive order has inflamed conservatives, who said it contradicts Texas' abstinence-only sexual education policies and intrudes into families' lives. Critics have previously questioned Perry's ties to Merck. Mike Toomey, Perry's former chief of staff, now lobbies for the drug company. And the governor accepted a total of $6,000 from Merck during his re-election campaign. Merck has waged a behind-the-scenes lobbying campaign to get state legislatures to require girls to get the three-dose vaccine to enroll in school. But on Tuesday the pharmaceutical company announced it was suspending the effort because of pressure from parents and medical groups. The Kentucky House on Thurday passed a bill that would require the vaccination for middle school girls unless their parents sign a form opposing it. Virginia lawmakers have also passed legislation requiring the vaccine, but the governor has not decided if he will sign it.
Note: The drug company lobby is the most powerful in the U.S., as reported by the former editor-in-chief of one of the most respected medical journals in the U.S. Click here for more.
Pediatricians, gynecologists and even health insurers all call Gardasil, the first vaccine to prevent cervical cancer, a big medical advance. But medical groups, politicians and parents began rebelling after disclosure of a behind-the-scenes lobbying campaign by Gardasil's maker, Merck & Co., to get state legislatures to require 11- and 12-year-old girls to get the three-dose vaccine as a requirement for school attendance. Some parents' groups and doctors particularly objected because the vaccine protects against a sexually transmitted disease. Vaccines mandated for school attendance usually are for diseases easily spread through casual contact, such as measles and mumps. Bowing to pressure, Merck said Tuesday that it is immediately suspending its controversial campaign, which it had funded through a third party. Legislatures in roughly 20 states have introduced measures that would mandate girls have the vaccine to attend school. Texas Gov. Rick Perry on Feb. 2 issued an executive order requiring Texas girls entering the sixth grade as of 2008 get the vaccinations. Dr. Anne Francis, who chairs an American Academy of Pediatrics committee [stated] "I believe that their timing was a little bit premature," she said, "so soon after (Gardasil's) release, before we have a picture of whether there are going to be any untoward side effects." The country has been "burned" by some drugs whose serious side effects emerged only after they were in wide use, including Merck's withdrawn painkiller Vioxx. The vaccine also is controversial because of its price - $360 for the three doses required.
Note: $360 for every girl in school would amount to quite a hefty transfer of funds from taxpayers into the pockets of Merck. Could profit and campaign contributions be behind the move to make this mandatory?
Cities should close schools for up to three months in the event of a severe flu outbreak, ball games and movies should be canceled ... the federal government advised today in issuing new pandemic flu guidelines to states and cities. Health officials acknowledged that such measures would hugely disrupt public life, but they argued that these measure would buy the time needed to produce vaccines and would save lives. “We have to be prepared for a Category 5 pandemic,” said Dr. Martin Cetron, director of global migration and quarantine for the Centers for Disease Control and Prevention. “It’s not easy. The only thing that’s harder is facing the consequences.” The new guidelines also advocate having sick people and all their families' even apparently healthy members stay home for 7 to 10 days. Any pandemic is expected to move faster than a new vaccine can be produced. Current experimental vaccines against H5N1 avian flu are in short supply and based on strains isolated in 2004 or 2005. Although the government is creating a $4 billion stockpile of the antiviral drug Tamiflu, it is only useful when taken within the first 48 hours, and Tamiflu-resistant flu strains have already been found. The historian John Barry, author of “The Great Influenza,” a history of the 1918 flu, questioned an idea underpinning the study’s conclusions. There is evidence, he said, that some cities with low sickness and death rates in 1918 ... were hit by a milder spring wave of the virus. That would have, in effect, inoculated their citizens against the more severe fall wave and might have been more important than their public health measures.
Note: Why is it that government officials seem to want us to be afraid? Could it be that when we live in fear, we are more willing to give up our freedoms and money and allow them to be in control? For more, click here. And why would the government spend billions on stockpiling drugs of questionable use? For an answer, click here.
The U.S. Food and Drug Administration said on Tuesday it would make organizational changes to improve internal communication about potential risks that emerge after a new drug reaches the market. The move is part of the agency's response to an Institute of Medicine (IOM) report that sharply criticized the FDA's drug safety oversight and called for more staffing, funding and power to police the drug industry. The September 2006 report also found a "dysfunctional" FDA structure that hindered the agency's ability to protect public health. The IOM experts said they found FDA officials had trouble managing scientific disagreements among staff and downplayed some concerns by safety reviewers who monitor drugs after they win approval. On Tuesday, the agency said it was "making specific organizational and management changes to increase communications among FDA review staff and safety staff." The announcement came as lawmakers prepare to debate critical funding legislation for the agency that could become a vehicle for drug safety reforms. The FDA had requested the IOM report after it came under harsh criticism for its handling of Merck & Co. Inc.'s withdrawn arthritis drug Vioxx and other medicines. Merck pulled Vioxx from the market in 2004, five years after its approval, because of a link to heart attacks and strokes.
Secret emails reveal that the UK's biggest drug company distorted trial results of an anti-depressant, covering up a link with suicide in teenagers. GlaxoSmithKline (GSK) attempted to show that Seroxat worked for depressed children despite failed clinical trials. And that GSK-employed ghostwriters influenced 'independent' academics. GSK faces action in the US where bereaved families have joined together to sue the company. As a result, GSK has been forced to open its confidential internal archive. Karen Barth Menzies is a partner in one of the firms representing many of the families. She has examined thousands of the documents which are stored, box upon box, in an apartment in Malibu, California. She said: "Even when they have negative studies that show that this drug Seroxat is going to harm some kids they still spin that study as remarkably effective and safe for children." An email from a public relations executive working for GSK ... said: "Originally we had planned to do extensive media relations surrounding this study until we actually viewed the results. Essentially the study did not really show it was effective in treating adolescent depression, which is not something we want to publicise." Seroxat was banned for under 18s in 2003 after the MHRA revealed that GSK's own studies showed the drug actually trebles the risk of suicidal thoughts and behaviour in depressed children.
Note: For more reliable information on how the drug companies put profits ahead of your health, click here.
Fluoride has become a controversial additive to our drinking water. While no one denies it can prevent cavities with topical application, a growing number of people, cities and countries have decided that ingesting unknown quantities of fluoride is a bad idea. One of Tennessee's own top health risk scientists is asking Gov. Phil Bredesen to stop adding fluoride to the water. Dr. Kathy Thiessen makes a living assessing health risks and has worked for the Center for Disease Control and Prevention and the Environmental Protection Agency. “The deliberate exposure to uncontrolled and unmonitored intake of fluoride is unwise at best and probably harmful to a substantial number of people,” Thiessen said. Thiessen joins Tennessee lawmaker and medical doctor Joey Hensley as the most prominent Tennessee voices against fluoride. Chris White is a musician with the band Loft, but his other passion is removing fluoride from Gallatin's water supply. “All parties point to the American Dental Association recommending that mothers stop using fluoridated water for baby formula as an obvious sign that fluoride is obviously not for everyone,” he said.
Note: This article fails to mention a key recent study showing "about 28 percent of the children in the low-fluoride area scored as bright, normal or higher intelligence compared to only 8 percent in the 'high' fluoride area. In the high-fluoride city, 15 percent had scores indicating mental retardation and only 6 percent in the low-fluoride city." For a truly awesome, revealing interview with a BBC producer on the major deceptions around and dangers of fluoride in water, click here. For more on this key topic from Dr. Mercola, click here. And for the top website on the risks and dangers of flouride in water, click here.
A new breed of lifestyle drugs could allow us to choose how much we sleep, boost our memories and even allow us to enjoy ourselves more, without any side effects. Will they unleash human capabilities never seen before or create a dystopian 24-hour society where we are dependent on drugs to regulate our lifestyle and behavior? One drug already available is modafinil, marketed as the vaguely Orwellian-sounding Provigil. It enables those who take it to stay awake and alert for 48 hours. It is a eugeroic that delivers a feeling of wakefulness without the physical or mental jitter. There is already a market for it for those without any medical need - it is developing a cult following among workaholics and students studying for exams. The military is also very interested in eugeroic. Their reliance on amphetamines for lengthy operations have had catastrophic consequences in the past. The "friendly-fire" incidents in Afghanistan in 2002 when U.S. pilots killed Canadian troops was blamed on the "go pills" they had taken. The U.S. Defense Advanced Research Projects Agency (DARPA) tested a compound called CX717 in its quest to find a drug that can create a "metabolically dominant war-fighter of the future" able to function for seven days without sleep. CX717 is an ampakine, a compound that increases the brains computing powers. It re-writes the rules of what it takes to create a memory and just how strong those memories can be. Will cans of soda containing eugeroics or ampakines be as common as caffeine drinks on the shelves of 24-hour stores? The potential is certainly there for a brave new world of personality medication.
There are no magic bullets in the fight against cancer: that's the first thing every responsible scientist mentions when discussing a possible new treatment, no matter how promising. If there were a magic bullet, though, it might be something like dichloroacetate, or DCA, a drug that kills cancer cells by exploiting a fundamental weakness found in a wide range of solid tumors. So far, though, it kills them just in test tubes and in rats infected with human cancer cells; it has never been tested against cancer in living human beings. DCA ... is an existing drug whose side effects are well-studied and relatively tolerable. Also, it's a small molecule that might be able to cross the blood-brain barrier to reach otherwise intractable brain tumors. Within days after a technical paper on DCA appeared in the journal Cancer Cell last week, the lead author, Dr. Evangelos Michelakis of the University of Alberta, was deluged with calls and e-mails from prospective patients—to whom he can say only, “Hang in there.” DCA is a remarkably simple molecule. It acts in the body to promote the activity of the mitochondria. Researchers have assumed that the mitochondria in cancer cells were irreparably damaged. But Michelakis wondered if that was really true. With his colleagues he used DCA to turn back on the mitochondria in cancer cells—which promptly died. One of the great things about DCA is that it's a simple compound, in the public domain, and could be produced for pennies a dose. But that's also a problem, because big drug companies are unlikely to spend a billion dollars or so on large-scale clinical trials for a compound they can't patent.
Note: Read a 2010 follow-up by Dr. Michelakis with promising results and watch a 10-minute video. Explore the DCA website. Why didn't other mass media report this major story? Why aren't many millions of dollars being poured into research? Notice even Newsweek acknowledges the drug companies are not interested in finding a cure for cancer if they can't make a profit from it. Some suspect the drug companies have even suppressed cancer cures found in the past. See one amazing example of this. For more, see these major media articles on potential cancer cures.
Dr. Brooke Herndon, an internist at Dartmouth-Hitchcock Medical Center, could not stop coughing. Dr. Kathryn Kirkland, an infectious disease specialist at Dartmouth, had a chilling thought: Could she be seeing the start of a whooping cough epidemic? By late April, other health care workers at the hospital were coughing. It was the start of a bizarre episode at the medical center: the story of the epidemic that wasn’t. For months, nearly everyone involved thought the medical center had had a huge whooping cough outbreak, with extensive ramifications. Nearly 1,000 health care workers ... were given a preliminary test and furloughed from work until their results were in; 142 people, including Dr. Herndon, were told they appeared to have the disease; and thousands were given antibiotics and a vaccine for protection. The whole thing was a false alarm. Now, as they look back on the episode, epidemiologists and infectious disease specialists say the problem was that they placed too much faith in a quick and highly sensitive molecular test that led them astray. Such tests are coming into increasing use and may be the only way to get a quick answer in diagnosing diseases like whooping cough, Legionnaire’s, bird flu, tuberculosis and SARS. There are no good estimates of their error rates. But their very sensitivity makes false positives likely, and when hundreds or thousands of people are tested, as occurred at Dartmouth, false positives can make it seem like there is an epidemic.
Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.
The two sides in the debate over genetically modified crops issued warring reports assessing the first decade of the technology this week, as the industry's sunny view clashed with the darker vision of critics. The world's farmland planted with biotechnology crops reached 252 million acres in 2006, the industry-backed International Service for the Acquisition of Agri-Biotech Applications calculated in a report ... that promotes the products as solutions for hunger and future fuel demand. The report concluded that biotechnology boosts crop yields and benefits the environment. That view was challenged by Friends of the Earth International and the Center for Food Safety in a report released Wednesday. The two groups argued that engineered plants don't produce larger harvests than conventional varieties, are often more vulnerable to drought and have increased the use of pesticides. The United States and Argentina host about 70 percent of the world's biotech crop acreage, both sides said. But adoption of the technology is growing at a faster rate in developing countries than in industrialized nations, according to the International Service. About 10 million farmers in 22 countries sow genetically modified crops, it said. The dominant biotech crop is soybeans, with 57 percent of world acreage, followed by maize, cotton and canola. Opponents said the crops are mainly a boon to agribusiness and big agricultural chemical companies trying to increase sales of seeds, weed-killers and bug sprays. Biotech crop seeds are often engineered to be resistant to the herbicides or pesticides sold by the same company.
Note: For reliable information showing that you may be eating genetically modified food every day which scientific experiments have repeatedly demonstrated can cause sickness and even death, click here.
Data supplied by tobacco companies strongly suggest that in recent years manufacturers deliberately boosted nicotine levels in cigarettes to more effectively hook smokers, Harvard researchers conclude in a study being released today. The companies increasingly used tobacco richer in nicotine and made design changes to give smokers more puffs per cigarette, according to the analysis from the Harvard School of Public Health. The report expands on a landmark Massachusetts Department of Public Health study issued last August showing that the amount of nicotine that could be inhaled from cigarettes increased an average of 10 percent from 1998 through 2004. A 1996 state law required cigarette makers to test the nicotine that could be inhaled from their products, and the state ordered the use of machines that simulate a typical smoker's puffing. The Harvard researchers, who corroborated the basic findings of the state study, wanted to determine why cigarettes were delivering more nicotine. "Industry says it's changed," said Greg Connolly, an author of the Harvard study. "They've changed -- maybe for the worse." The Harvard study relies on information supplied by the industry. "It was systematic, it was pervasive, it involved all the manufacturers, and it was by design," said Dr. Howard Koh, an associate dean at the Harvard School of Public Health and an author of the study. Another author said that the likelihood that the nicotine increase happened by chance was less than 1 in 1,000.
In results that "astounded" scientists, an inexpensive molecule known as DCA was shown to shrink lung, breast and brain tumours in both animal and human tissue experiments. The study was published yesterday in the journal Cancer Cell. "I think DCA can be selective for cancer because it attacks a fundamental process of cancer that is unique to cancer cells," said Dr. Evangelos Michelakis, a professor at the Edmonton university's medical school and one of the study's key authors. The molecule appears to repair damaged mitochondria in cancer cells. "When a cell is getting too old or doesn't function properly, the mitochondria are going to induce the cell death," lead study author Sebastien Bonnet said yesterday. Bonnet says DCA – or dichloroacetate – appears to reverse the mitochondrial changes in a wide range of cancers. "One of the really exciting things about this compound is that it might be able to treat many different forms of cancer because all forms of cancer suppress mitochondrial function," Michelakis said. Bonnet says DCA may also provide an effective cancer treatment because its small size allows easy absorption into the body, ensuring it can reach areas that other drugs cannot, such as brain tumours. Because it's been used to combat other ailments ... DCA has been shown to have few toxic effects on the body. Its previous use means it can be immediately tested on humans. Unlike other cancer drugs, DCA did not appear to have any negative effect on normal cells. It could provide an extremely inexpensive cancer therapy because it's not patented. But ... the lack of a patent could lead to an unwillingness on the part of pharmaceutical companies to fund expensive clinical trials.
Note: Even these scientists realize that though this discovery could be a huge benefit to mankind, because the drug companies will lose profits, they almost certainly will not fund studies. Expensive AIDS drugs with promising results, on the other hand, are rushed through the studies to market. For more reliable, verifiable information on how hugely beneficial health advances are shut down to keep profits high, click here and here.
A team at the institute that cloned Dolly the sheep have made a genetically engineered chicken that produces cancer drugs in its eggs. The chickens produce the cancer drugs in their egg whites, the team at the Roslin Biocentre in Edinburgh reported. The drugs include a monoclonal antibody — themselves lab-engineered immune system proteins — and a human immune system protein used to treat cancer and other conditions. Scientists have been trying to find good ways to turn animals into factories. Cattle, sheep and goats all have been genetically engineered to produce human proteins in their milk, including insulin and drugs to treat cystic fibrosis, but the Roslin team thought chickens, with their shorter life cycles and egg-laying prowess, also might be useful. They used a virus to infect very early chicken embryos. The virus inserted the genetic material into the DNA of chick embryos in newly laid eggs. The researchers hatched these chicks and found the male chicks who had indeed incorporated the new DNA in their semen. These cockerels were then bred with normal hens and they screened the resulting chicks to see which ones still carried the two new genes. The researchers have now bred several hundred chickens that can produce the desired proteins. Other companies have created animals and plants that produce human and animal proteins, as well as vaccines.
Note: It's a brave new world. For more on genetically modified organisms, click here.
Two UK-based academics have devised a way to invent new medicines and get them to market at a fraction of the cost charged by big drug companies. Sunil Shaunak, professor of infectious diseases at Imperial College ... calls their revolutionary new model "ethical pharmaceuticals". Improvements they devise to the molecular structure of an existing, expensive drug turn it technically into a new medicine which is no longer under a 20-year patent to a multinational drug company and can be made and sold cheaply. The process has the potential to undermine the monopoly of the big drug companies and bring cheaper drugs not only to poor countries but back to the UK. Professor Shaunak and his colleague from the London School of Pharmacy, Steve Brocchini, have linked up with an Indian biotech company which will manufacture the first drug - for hepatitis C. Hepatitis C affects 170 million people worldwide and at least 200,000 in the UK. Multinational drug companies put the cost of the research and development of a new drug at $800m (Ł408m). Professors Shaunak and Brocchini say the cost of theirs will be only a few million pounds. Professor Shaunak says it is time that the monopoly on drug invention and production by multinational corporations - which charge high prices because they need to make big profits for their shareholders - was broken. The team's work on the hepatitis C drug has impeccable establishment credentials. But the professors' ethical pharmaceutical model is unlikely to find much favour with the multinational pharmaceutical companies, which already employ large teams of lawyers to defend the patents which they describe as the lifeblood of the industry.
Note: This is very exciting news, but we'll see what happens when the hugely profitable pharmaceutical industry presses its might against this effort. For more, click here.
Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.